Azizi Soheil, Tabary Shervin Ziabakhsh, Soleimani Arya
Med Arch. 2014;68(2):137-9. doi: 10.5455/medarh.2014.68.137-139.
Although blood transfusion is life saving for patients, it is responsible for a series of complications and exposes the patients to a variety of risks. Therefore knowing different adverse effects of blood transfusion represents a great issue in managing recipient patients.
The aim of the present work was to study the prevalence of blood transfusion complications among patients in the Mazandaran Heart Center, Sari, Iran, during a period of 2 years.
A retrospective review of all reported and evaluated acute transfusion reactions during a 2 years period in Mazandaran Heart Center was performed. Associated clinical signs and symptoms were evaluated.
In 9193 transfused blood products, there was 34 (0.4%) acute transfusion reactions. The commonest were discomfort and restlessness (0.16%), dyspnea (0.16%), rigors (0.13%), fever (0.08%), chest pain (0.06%), rash or urticaria (0.04%), nausea and vomiting (0.03%), palpitation (0.03%), hypertension (0.03%) flashing (0.02%), hypotension (0.02%).
Acute transfusion reaction is seen in %0.4 of transfused patients therefore, we recommend a well-structured program for monitoring adverse reactions associated with blood transfusion and blood product administration (Hemovigilance program).
尽管输血对患者来说是救命之举，但它会引发一系列并发症，并使患者面临各种风险。因此，了解输血的不同不良反应是管理受血患者的一个重大问题。
本研究的目的是调查伊朗萨里市马赞德兰心脏中心患者在两年期间输血并发症的发生率。
对马赞德兰心脏中心两年期间所有报告并评估的急性输血反应进行回顾性研究。对相关临床体征和症状进行评估。
在9193份输注的血液制品中，有34例（0.4%）发生急性输血反应。最常见的是不适与烦躁不安（0.16%）、呼吸困难（0.16%）、寒战（0.13%）、发热（0.08%）、胸痛（0.06%）、皮疹或荨麻疹（0.04%）、恶心和呕吐（0.03%）、心悸（0.03%）、高血压（0.03%）、头晕（0.02%）、低血压（0.02%）。
0.4%的受血患者会出现急性输血反应，因此，我们建议制定一个结构完善的方案来监测与输血及血液制品输注相关的不良反应（血液警戒方案）。
